课题基金 / 基金详情

DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS

DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS
患有 AML 或先天性缺陷儿童的 BMT 中白消安的剂量调整
批准号：
6280809
负责人：
ANN BOLINGER
金额：
$2.39万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6280809
关键词：
acute myelogenous leukemia bone marrow transplantation busulfan child (0-11) clinical research combination cancer therapy dosage human subject human therapy evaluation neoplasm /cancer chemotherapy pediatric pharmacology

项目摘要

项目成果

ANN BOLINGER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a study to determine whether there is increased engraftment along with decreased severe toxicity following a BMT when a specific busulfan concentration at steady state is administered during the conditioning phase of treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS
BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION
BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION
DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS
海外基金